Clinical Topics & News

308-nm UVB Excimer Laser Versus Nontargeted Phototherapy

Publish date: November 9, 2012
By
Steven R. Feldman, MD, PhD
Author and Disclosure Information

Dr. Feldman discusses UVB phototherapy for the treatment of psoriasis. For more information, read Dr. Feldman's article from the September 2012 issue, "Therapeutic Modalities for Localized Psoriasis: 308-nm UVB Excimer Laser Versus Nontargeted Phototherapy."

 

Recommended Reading

Experience Proved Rituximab Best for Vasculitis
MDedge Dermatology
Psoriasis Plus Diabetes Equals Heightened Vascular Risk
MDedge Dermatology
EULAR's Lupus Nephritis Guidelines Emphasize Early Biopsy
MDedge Dermatology
Psoriasis Flares Rapidly Postpartum
MDedge Dermatology
Psoriasis: Short-Course Clobetasol Enhances Etanercept Outcomes
MDedge Dermatology
Indirect Comparison Trial Favors Adalimumab for Psoriasis
MDedge Dermatology
Game Changer? First JAK Inhibitor Approved for Rheumatoid Arthritis
MDedge Dermatology
Secukinumab Tames Hand, Foot Psoriasis
MDedge Dermatology
Oral JAK Inhibitor's Clinical Place To Be Determined
MDedge Dermatology
Adalimumab for the Treatment of Pityriasis Rubra Pilaris: A Case Report
MDedge Dermatology